About this trial
The goal of this interventional study is to evaluate the effect of mobile health intervention on frailty, physical fitness, physical activity, and nutritional status of elderly patients with colorectal cancer. The main questions it aim to answer are: 1. Does the mobile health intervention reduce frailty in elderly colorectal cancer patients compared to standard care? 2. Does the mobile health intervention improve physical fitness, physical activity, and nutritional status in elderly colorectal cancer patients compared to standard care? Participants will receive the Mobile Health Management Frailty Care Program.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients diagnosed with colorectal cancer confirmed by a physician.
Aged 60 and above.
Have communication skills, able to read and write or converse in Mandarin and Taiwanese.
Clear consciousness and no mental or cognitive impairment.
Disqualifiers
People who have difficulty walking or standing.
The wrist is not suitable for those wearing sports bracelets.
People in infectious or protective isolation.
Those who live alone or in institutions.
Trial design
Parallel
Treatments tested in this trial
Mobile Health Management Frailty Care Program
BehavioralThrough the "LINE" communication software, participants are provided with exercise and nutrition information three times a week, with a total of 36 messages. As well as 6 podcasts of health information and 6 sports videos in total. At weeks 2, 4, and 6, researchers scheduled 5- to 10-minute telephone consultations. Participants can receive guidance through telephone consultations and carry a Xiaomi sports band wearable device to monitor their exercise.
Treatment groups
Trial outcomes
Primary outcomes
Frailty
Assessing frailty status using the G8 geriatric screening tool. Scores range from 0 to 17, with 0 indicating severe impairment and 17 indicating no impairment. The lower the score, the more frail it is.
Physical Activity
Assess physical activity with the International Physical Activity Questionnaire-Short Form. The IPAQ-SF evaluates the number of days and time spent performing MVPA, walking, and sitting in bouts of at least 10 min over the previous 7 days. The summary score is expressed in PA metabolic equivalent of task (MET)-min per day or week.
Nutritional Status
Assess nutritional status with Mini Nutritional Assessment-Short Form. The total score is 0-14 points. A score of 12 or more indicates a low risk of malnutrition. A score of 8-11 indicates a potential risk of malnutrition. A score less than 7 indicates a high risk of malnutrition.
Secondary outcomes
health-related quality of life
Assessing quality of life using Taiwan Chinese version of European Organization for Research and Treatment of Cancer questionnaires. For all scales, item scores are summed and linearly transformed into a scale ranging from 0 to 100. Higher scores on the functioning scales indicate higher levels of functioning
Depression
Assessing depression level using the Geriatric Depression Scale Short Form. The higher the score, the higher the degree of depression. 0-4 indicates normal, 5-10 indicates slight tendency to depression, and 10 or more indicates symptoms of depression.
body mass index
Body mass index is calculated by dividing weight (kg) by height (meters) squared. The normal range is 18.5 ≦ BMI \< 24. Less than 18.5 represents underweight; 24 ≦ BMI \<27 represents overweight; 27 ≦ BM I\<30 represents mild obesity; 30 ≦ BMI \<35 represents moderate obesity; BMI ≧35 represents severe obesity.
hand grip strength
Hand grip strength (in kilograms) was measured using a digital hand dynamometer (EH101; Camry, Guangdong Province, China). The grip strength of the dominant hand was assessed three times, and the maximal value was considered for analysis. The definition of normal GS according to European Working Group on Sarcopenia in Older People (EWGSOP) was ≥ 30kg in the male and ≥ 20 kg in the female. Weak GS was defined as GS \< 30 kg in the male and GS \< 20 kg in the female.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.